Advion BioSystems and Ion Beam Applications (IBA) Announce Non-exclusive Agent Agreement for Advion's NanoTek Microfluidic Synthesis System with IBA's Cyclotrons

Dedicated to Science, Dedicated to You

ITHACA, NY, USA and Louvain-LA-Neuve, Belgium, June 13, 2009 — Advion BioSystems, Inc. and Ion Beam Applications (IBA) jointly announced today a new agreement for IBA to be a world-wide non-exclusive agent for the Advion NanoTek Microfluidic Synthesis System (NanoTek). Under the agreement, IBA will focus their efforts on offering the NanoTek as an optional accessory when proposing solutions for turnkey cyclotron projects involved with Positron Emission Tomography (PET). IBA will also offer it to existing installed base cyclotrons.

Said Peter Leitner, Sales & Marketing Director of IBA, “Our cyclotrons are used in many leading PET research centres around the world, and we are pleased to be able to offer our customers access to this exciting new technology from Advion.”

Dave Patteson, CEO of Advion, added, “This agreement will widen our distribution channels, enabling us to participate in the world wide market for turnkey PET radiochemistry departments.”

PET, which uses specific biomarkers labeled with small amounts of radioactivity, is a powerful technique used in both clinical diagnostic medicine and in advanced medical research and pharmaceutical development. The core technology of the NanoTek, microfluidic flow chemistry, is rapidly proving to be an attractive alternative to conventional vial-based chemistry for the radiochemical labeling. The advantages include reduced reaction times and higher radiochemical yields. Researchers, who have already incorporated the NanoTek into their labs, report being able to conduct multiple sequential syntheses from one delivery of radioisotope, greatly accelerating the optimization of new compounds.

About IBA
Founded in 1986 in Louvain-la-Neuve , Belgium , IBA is primarily active in the medical industry. It develops and markets state-of-the-art equipment and radiopharmaceuticals for cancer diagnosis and treatment. In addition, it uses the scientific expertise thus gained to provide electron accelerators for industrial sterilization and ionization.

About Advion BioSystems, Inc.
Advion is the scientific leader in microfluidic systems. The company’s scientific knowledge base creates unique nanotechnologies delivering speed, flexibility, and exceptional data quality. Advion is the microfluidics supplier of choice for customers demanding scientific excellence, more information from complex samples, and greater throughput. More about the company can be found at

For Advion:
Heather Scollins
Sr. Marketing Communication Specialist
Advion BioSciences, Inc.
p: 1.607.266.0665 ext. 333